Insights
Insights
Insights
IP Law Essentials August 12, 2020
How Biosimilars Are Approved and Litigated: Patent Dance Timeline
Blog July 10, 2020
Chief Judge Stark Dismisses Hatch-Waxman Case after Paragraph IV to Paragraph III Conversion
Blog June 22, 2020
FDA Seeks to Modernize the Orange Book
IP Law Essentials June 4, 2020
Introduction to Biologics and Biosimilars
IP Law Essentials May 21, 2020
Overview of Approaches to Compulsory Licensing
IP Law Essentials May 1, 2020
Where Do Juries Come From?
Blog April 20, 2020
A Biosimilar's Guide to the BPCIA Patent Dance: Five Key Questions for Every Biosimilar Applicant to Consider
Blog March 20, 2020
Insulin and Other Biological Products Previously Regulated as "Drugs" Transition to Biologics Regulation on March 23, 2020
Blog February 7, 2020
Increasing Competition in the Biologic Market Through Truthful Advertising
News